UBS Group
RBOT

UBS Group’s Vicarious Surgical RBOT Stock Holding History

UBS Group’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$11 – 11049
2025
Q4 		$11 Sell
5
-3,189
-100% -$13K ﹤0.01% 10380
2025
Q3 		$17.6K Buy
3,194
+3,050
+2,118% +$23.3K ﹤0.01% 8240
2025
Q2 		$1.08K Sell
144
-2,330
-94% -$16.9K ﹤0.01% 9675
2025
Q1 		$16.2K Buy
2,474
+2,444
+8,147% +$28.9K ﹤0.01% 8362
2024
Q4 		$395 Buy
+30
New +$309 ﹤0.01% 9489
2024
Q3 		– Sell
-1
Closed -$6 – 9969
2024
Q2 		$6 Sell
1
-3,230
-100% -$28.9K ﹤0.01% 9389
2024
Q1 		$29.2K Sell
3,231
-696
-18% -$8.3K ﹤0.01% 6754
2023
Q4 		$43.2K Buy
3,927
+2,358
+150% +$26.3K ﹤0.01% 6626
2023
Q3 		$27.8K Buy
1,569
+196
+14% +$7.14K ﹤0.01% 6626
2023
Q2 		$75.4K Sell
1,373
-777
-36% -$49.5K ﹤0.01% 6214
2023
Q1 		$146K Sell
2,150
-4,521
-68% -$352K ﹤0.01% 5629
2022
Q4 		$404K Buy
6,671
+2,779
+71% +$258K ﹤0.01% 4884
2022
Q3 		$391K Buy
3,892
+188
+5% +$21.9K ﹤0.01% 4553
2022
Q2 		$326K Buy
3,704
+561
+18% +$68.6K ﹤0.01% 4580
2022
Q1 		$477K Buy
3,143
+3,140
+104,667% +$584K ﹤0.01% 4730
2021
Q4 		$1K Sell
3
-105
-97% -$37K ﹤0.01% 10026
2021
Q3 		$49K Sell
108
-454
-81% -$144K ﹤0.01% 6357
2021
Q2 		$168K Buy
562
+91
+19% +$27.1K ﹤0.01% 5487
2021
Q1 		$140K Sell
471
-1,138
-71% -$348K ﹤0.01% 5707
2020
Q4 		$491K Buy
1,609
+1,596
+12,277% +$469K ﹤0.01% 4611
2020
Q3 		$4K Buy
+13
New +$3.82K ﹤0.01% 7430

Other funds holding RBOT

AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
FFG
Forum Finance Group Geneva $184M AUM
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

UBS Group's RBOT Position: Q1 2026 in Review

UBS Group sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 5 shares — an estimated $11 sold.

UBS Group first reported a position in RBOT in Q3 2020 and held it in 21 quarters. The position peaked at $491K in Q4 2020. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • UBS Group reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 5 Vicarious Surgical shares in Q1 2026, an estimated $11.
  • UBS Group first reported a position in Vicarious Surgical in Q3 2020 and held it in 21 quarters.
  • UBS Group's Vicarious Surgical position peaked at $491K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.